Market Overview:
The global blood thinner market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, rising geriatric population, and technological advancements in the field of blood thinners. Based on type, the global blood thinner market is segmented into injectable blood thinners and oral blood thinners. Injectable blood thinners are further sub-segmented into unfractionated heparin (UFH), low molecular weight heparins (LMWHs), direct thrombin inhibitors (DTIs), and factor Xa inhibitors (FXaIs). Oral anticoagulants are further sub-segmented into vitamin K antagonists (VKAs) such as warfarin, novel oral anticoagulants (NOACs) such as dabigatran etexilate mesylate, rivaroxaban, apixaban and edoxaban, and antiplatelet agents such as aspirin and clopidogrel. Based on application, the globalblood thinnermarket is segmentedinto hospital pharmacies,, retail pharmacies,, online pharmacies,,and others). Geographically,. North America dominates theglobalblood thinnermarket followed by Europeand Asia Pacific region. However,.
Product Definition:
A blood thinner is a medication that helps to prevent the formation of blood clots. They are used to treat and prevent conditions such as deep vein thrombosis, pulmonary embolism, and stroke.
Injectable Blood Thinners:
Injectable blood thinners are drugs that are administered to reduce the tendency of blood to clot. They do not prevent bleeding but rather help in reducing the amount of blood that is lost during injury or surgery. In addition, they also have applications in cancer treatment and management as well as for patients undergoing dialysis.
Rising prevalence of chronic diseases such as cardiovascular diseases, cancer, diabetes.
Oral Blood Thinners:
Oral blood thinners are drugs used to prevent or reduce the tendency of blood to clot. They may be prescribed for people with high risk of bleeding such as patients on warfarin, aspirin, and other medications that increase the chance of bleeding. Some oral blood thinner also act as anti-inflammatory drugs and hence can be used in place of non-steroidal anti-inflammatory drugs (NSAIDs).
Application Insights:
Based on the application, the global market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. The hospital pharmacy segment dominated the market in 2017 owing to increasing usage of blood thinners for various conditions in hospitals. Blood thinner injections are used as a preventive measure against cardiovascular diseases and other associated conditions. As a result, demand for these products from hospitals is expected to drive growth over the forecast period.
The online pharmacy sector is anticipated to witness significant growth over the forecast period due to increase in availability of various payment options such as PayPal and Google Pay that make it easier for consumers purchase these drugs from remote locations without visiting doctors or pharmacists stores physically near them. Moreover, growing awareness about purchasing medicines through online pharmacies due to extensive advertising by pharmaceutical companies will further boost industry growth during this period.
Regional Analysis:
North America dominated the global blood thinner market in 2017. The region is expected to maintain its position during the forecast period. Increasing prevalence of cardiovascular diseases, rising geriatric population, and growing healthcare expenditure are some of the major factors contributing to market growth in this region. Moreover, presence of key pharmaceutical companies such as Pfizer Inc.; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Bristol-Myers Squibb Company; and AbbVie Inc., is also likely to contribute towards regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging countries such as China and India.
Growth Factors:
- Increasing incidence of blood clotting disorders and thrombosis
- Growing demand for minimally invasive surgeries
- Rising awareness about the benefits of blood thinners
- Technological advancements in the field of blood thinner drugs and devices
- increasing prevalence of lifestyle diseases such as obesity and diabetes
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Thinner Market Research Report
By Type
Injectable Blood Thinners, Oral Blood Thinners
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Companies
Bayer, Pfizer, Merck, Sanofi, Abbott Laboratories, Johnson and Johnson, Baxter International, AstraZeneca, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Blood Thinner Market Report Segments:
The global Blood Thinner market is segmented on the basis of:
Types
Injectable Blood Thinners, Oral Blood Thinners
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Pfizer
- Merck
- Sanofi
- Abbott Laboratories
- Johnson and Johnson
- Baxter International
- AstraZeneca
- Bayer
Highlights of The Blood Thinner Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injectable Blood Thinners
- Oral Blood Thinners
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Thinner Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood thinner is a medication that helps to reduce the amount of blood flowing in your veins. This can help to prevent clots from forming and traveling to your heart or other organs.
Some of the major companies in the blood thinner market are Bayer, Pfizer, Merck, Sanofi, Abbott Laboratories, Johnson and Johnson, Baxter International, AstraZeneca, Bayer.
The blood thinner market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Thinner Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Thinner Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Thinner Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Thinner Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Thinner Market Size & Forecast, 2018-2028
4.5.1 Blood Thinner Market Size and Y-o-Y Growth
4.5.2 Blood Thinner Market Absolute $ Opportunity
Chapter 5 Global Blood Thinner Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Thinner Market Size Forecast by Type
5.2.1 Injectable Blood Thinners
5.2.2 Oral Blood Thinners
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Thinner Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Thinner Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Thinner Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Thinner Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Thinner Analysis and Forecast
9.1 Introduction
9.2 North America Blood Thinner Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Thinner Market Size Forecast by Type
9.6.1 Injectable Blood Thinners
9.6.2 Oral Blood Thinners
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Thinner Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Thinner Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Thinner Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Thinner Market Size Forecast by Type
10.6.1 Injectable Blood Thinners
10.6.2 Oral Blood Thinners
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Thinner Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Thinner Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Thinner Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Thinner Market Size Forecast by Type
11.6.1 Injectable Blood Thinners
11.6.2 Oral Blood Thinners
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Thinner Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Thinner Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Thinner Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Thinner Market Size Forecast by Type
12.6.1 Injectable Blood Thinners
12.6.2 Oral Blood Thinners
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Thinner Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Thinner Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Thinner Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Thinner Market Size Forecast by Type
13.6.1 Injectable Blood Thinners
13.6.2 Oral Blood Thinners
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Thinner Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Thinner Market: Competitive Dashboard
14.2 Global Blood Thinner Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Pfizer
14.3.3 Merck
14.3.4 Sanofi
14.3.5 Abbott Laboratories
14.3.6 Johnson and Johnson
14.3.7 Baxter International
14.3.8 AstraZeneca
14.3.9 Bayer
